Acute Coronary Syndromes in the Elderly

Clinics in Geriatric Medicine

Volumn 23, Issue 2, 2007, Pages 425-440

  Majeed, Farhan ^a   Kelemen, Mark D ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ARGATROBAN; ATORVASTATIN; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DESULFATOHIRUDIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EFEGATRAN; ENOXAPARIN; HEPARIN; HIRUDIN; HIRULOG; INOGATRAN; LEPIRUDIN; METOPROLOL; NITRIC ACID DERIVATIVE; PRAVASTATIN; THROMBIN INHIBITOR; TICLOPIDINE;

ACUTE CORONARY SYNDROME; AGED; AGING; BLOOD CLOT LYSIS; CLINICAL TRIAL; ELDERLY CARE; HEART MUSCLE ISCHEMIA; HEART REHABILITATION; HUMAN; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; RECOMMENDED DRUG DOSE; REPERFUSION; REVIEW; RISK FACTOR; THORAX PAIN; TREATMENT CONTRAINDICATION;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGING; ANGINA, UNSTABLE; ANTICOAGULANTS; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PLATELET AGGREGATION INHIBITORS; SYNDROME;

EID: 34247227693     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cger.2007.01.004     Document Type: Review

References (65)

1. Centers for Disease Control and Prevention. Annual smoking-attributable mortality, years of potential life lost, and economic costs-United States, 1995-1999. MMWR Morb Mortal Wkly Rep 51 (2002) 300-303
2. American Heart Association. Heart disease and stroke statistics-2004 update (2003), American Heart Association, Dallas (TX)
3. Wenger N.K. Cardiovascular disease in the elderly. Curr Probl Cardiol 17 (1992) 609-690
4. Goldberg R.J., McCormick D., Gurwitz J.H., et al. Age-related trends in short- and long-term survival after acute myocardial infarction: a 20-year population-based perspective (1975-1995). Am J Cardiol 82 (1998) 1311-1317
5. White H.D., Barbash G.I., Califf R.M., et al. Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries trial. Circulation 94 (1996) 1826-1833
6. Stone P.H., Thompson B., Anderson H.V., et al. Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: the TIMI III registry. JAMA 275 (1996) 1104-1112
7. Schulman S.P., Lakatta E.G., Fleg J.L., et al. Age-related decline in left ventricular filling at rest and exercise. Am J Physiol 263 (1992) H1932-H1938
8. Davies C.H., Ferrara N., and Harding S.E. Beta-adrenoceptor function changes with age of subject in myocytes from non-failing human ventricle. Cardiovasc Res 31 (1996) 152-156
9. Vaitkevicius P.V., Fleg J.L., Engel J.H., et al. Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation 88 (1993) 1456-1462
10. Kurotobi T., Sato H., Kinjo K., et al., for the OACIS Group. Reduced collateral circulation to the infarct-related artery in elderly patients with acute myocardial infarction. J Am Coll Cardiol 44 1 (2004) 28-34
11. Abete P., Ferrara N., Cacciatore F., et al. Angina-induced protection against myocardial infarction in adult and elderly patients: a loss of preconditioning mechanisms in the aging heart?. J Am Coll Cardiol 30 4 (1997) 947-954
12. Braunwald E., Antman E.M., Beasley J.W., et al. ACC/AHA 2003 guideline update for the management of patients with unstable angina and non-ST elevation myocardial infarction-summary article. J Am Coll Cardiol 40 (2002) 1366-1374
13. Krumholz H.M., Radford M.J., Wang Y., et al. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA 280 7 (1998) 623-629
14. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina); 2002.
15. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 345 8951 (1995) 669-685
16. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 343 8906 (1994) 1115-1122
17. Yusuf S., Wittes J., and Friedman L. Overview of results of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification. JAMA 260 15 (1988) 2259-2263
18. Hennekens C.H., Albert C.M., Godfried S.L., et al. Adjunctive drug therapy of acute myocardial infarction-evidence from clinical trials. N Engl J Med 335 22 (1996) 1660-1667
19. Ryan T.J., Antman E.M., Brooks N.H., et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 34 3 (1999) 890-911
20. Lewis Jr. H.D., Davis J.W., Archibald D.G., et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. N Engl J Med 309 7 (1983) 396-403
21. Expert Panel of Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 19 (2001) 2486-2497
22. Theroux P., Ouimet H., McCans J., et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 319 17 (1988) 1105-1111
23. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet 2 8607 (1988) 349-360
24. The CURE investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345 7 (2001) 494-502
25. Mehta S.R., Yusuf S., Peters R.J., et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358 9281 (2001) 527-533
26. Boersma E., Harrington R.A., Moliterno D.J., et al. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomized clinical trials. Lancet 359 9302 (2002) 189-198
27. GUSTO IV-ACS Investigators. Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularization: the GUSTO IV-ACS randomized trial. Lancet 357 9272 (2001) 1915-1924
28. Brown D.L., Fann C.S., and Chang C.J. Meta-analysis of effectiveness and safety of abciximab versus eptifibatide or tirofiban in percutaneous coronary intervention. Am J Cardiol 87 5 (2001) 537-541
29. Oler A., Whooley M.A., Oler J., et al. Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis. JAMA 276 10 (1996) 811-815
30. Cohen M., Demers C., Gurfinkel E.P., et al. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Enoxaparin in Non-Q-wave Coronary Events Study Group. N Engl J Med 337 (1997) 447-452
31. Antman E.M., McCabe C.H., Gurfinkel E.P., et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 11B Trial. Circulation 100 (1999) 1593-1601
32. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) 11b Investigators. N Engl J Med 335 (1996) 775-782
33. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators. Lancet 353 9151 (1999) 429-438
34. Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1). Lancet 345 (1995) 686-687
35. Pfeffer M.A., Braunwald E., Moye L.A., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327 (1992) 669-677
36. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Lancet 342 (1993) 821-828
37. Fonarow G.C., Gawlinski A., Moughrabi S., et al. Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). Am J Cardiol 87 (2001) 819-822
38. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 344 (1994) 1383-1389
39. Sacks F.M., Pfeffer M.A., Moye L.A., et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial Investigators. N Engl J Med 335 (1996) 1001-1009
40. Schwartz G.G., Olsson A.G., Ezekowitz M.D., et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomised controlled trial. JAMA 285 (2001) 1711-1718
41. Cannon C.P., Braunwald E., McCabe C.H., et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350 (2004) 1495-1504
42. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 343 (1994) 311-322
43. Mahaffey K.W., Granger C.B., Sloan M.A., et al. Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-I. Circulation 97 (1998) 757-764
44. Thiemann D.R., Coresh J., Schulman S.P., et al. Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation 101 19 (2000) 2239-2246
45. Antman E., Anbe D., Armstrong P., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 110 (2004) 588-636
46. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. Circulation 89 (1994) 1545-1556
47. Weaver W., Simes R., Betriu A., et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 278 (1997) 2093-2098
48. Keeley E., Boura J., and Grines C. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361 (2003) 13-20
49. De Boer M.J., Ottervanger J.P., Van't Hof A.W., et al., for the Zwolle Myocardial Infarction Study Group. Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy. J Am Coll Cardiol 39 11 (2002) 1723-1728
50. Aversano T., Aversano L.T., Passamani E., et al., for the Atlantic Cardiovascular Patient Outcomes Research Team (C-PORT). Thrombolytic therapy vs. primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospital without on-site cardiac surgery: a randomised controlled trial. JAMA 287 (2002) 1943-1951
51. Grines C.L., Westerhausen Jr. D.R., Grines L.L., et al., for the Air PAMI Study Group. A randomised trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the air primary angioplasty in myocardial infarction study. J Am Coll Cardiol 39 (2002) 1713-1719
52. Andersen H.R., Nielsen T.T., Rasmussen K., et al., for the DAMANI-2 Investigators. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 349 (2003) 733-742
53. Widimsky P., Budesinsky T., Vorac D., et al., for the PRAGUE Study Group Investigators. Long distance transport for primary angioplasty vs. immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial-PRAGUE-2. Eur Heart J 24 (2003) 94-104
54. Fox K., Poole-Wilson P., Henderson R., et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Lancet 360 (2002) 743-751
55. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet 354 9180 (1999) 708-715
56. Cannon C.P., Weintraub W.S., Demopoulos L.A., et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 344 25 (2001) 1879-1887
57. Boden W.E., O'Rourke R.A., Crawford M.H., et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. N Engl J Med 338 25 (1998) 1785-1792
58. Balady G.J., Ades P.A., Comoss P., et al. Core components of cardiac rehabilitation/secondary prevention programs: a statement for healthcare professionals from the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation Writing Group. Circulation 102 9 (2000) 1069-1073
59. American Association of Cardiovascular and Pulmonary Rehabilitation. Guidelines for cardiac rehabilitation and secondary prevention program. 3rd edition (1999), Human Kinetics, Champaign (IL)
60. Evenson K.R., Rosamond W.D., and Luepker R.V. Predictors of outpatient cardiac rehabilitation utilization: the Minnesota Heart Surgery Registry. J Cardiopulm Rehabil 18 3 (1998) 192-198
61. Lavie C.J., Milani R.V., Cassidy M.M., et al. Benefits of cardiac rehabilitation and exercise training in older persons. Am J Geriatr Cardiol 4 4 (1995) 42-48
62. Wenger NK, Froelicher ES, Smith LK, et al. Cardiac rehabilitation. Clinical practice guideline no. 17. U.S. Department of Health and Human Services, Public Health Service Agency for Health Care Policy and Research and the National Heart, Lung, and Blood Institute. AHCPR Publication No. 96-0672. October 1995.
63. Taylor R.S., Brown A., Ebrahim S., et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 116 (2004) 682-692
64. Steffen-Batey L., Nichaman M.Z., Goff Jr. D.C., et al. Change in level of physical activity and risk of all-cause mortality or reinfarction: The Corpus Christi Heart Project. Circulation 102 (2000) 2204-2209
65. Bondestam E., Breikss A., and Hartford M. Effects of early rehabilitation on consumption of medical care during the first year after acute myocardial infarction in patients > or = 65 years of age. Am J Cardiol 75 12 (1995) 767-771